New stroke drug shows promise in recovery trial
Disease control
Completed
This study tested a new medicine called MLC1501 to help people recover after a stroke. 303 adults who had a stroke within the past 2 to 10 days took either a high dose, low dose, or a placebo pill twice a day for 24 weeks. The main goal was to see if MLC1501 improves motor functi…
Phase: PHASE2 • Sponsor: Moleac Pte Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC